ve started with Hepsera, there is no need to change. He felt that the resisitance rate for Hepsera (
vs.
Viread and
Baraclude) is overstated; many patients develop no resistance at all, and the resistance rate, while higher than those for Viread/Baraclude, is not that much higher. Plus, if you do develop resistance, that's when you should start taking Viread (as mono or combo, he didn't say). And Viread is very effective in stopping Hepsera resistance.